4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide

C20H32F2IN5O — CID 109450574

IUPAC4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide
SMILESC/N=C(\NCC(C)N1CCOCC1C)N1CCN(c2cc(F)ccc2F)CC1.I
InChIInChI=1S/C20H31F2N5O.HI/c1-15(27-10-11-28-14-16(27)2)13-24-20(23-3)26-8-6-25(7-9-26)19-12-17(21)4-5-18(19)22;/h4-5,12,15-16H,6-11,13-14H2,1-3H3,(H,23,24);1H
InChIKeyIVARJRAUKXOWBL-UHFFFAOYSA-N
MW523.41 g/mol
LogP2.39
Rot. Bonds4

About 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide

4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide (PubChem CID 109450574) has the molecular formula C20H32F2IN5O and a molecular weight of 523.41 g/mol. Its IUPAC name is 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide.

Molecular Properties

Compound Name4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide
PubChem CID109450574
Molecular FormulaC20H32F2IN5O
Molecular Weight523.41 g/mol
Exact Mass523.16
IUPAC Name4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide
SMILESC/N=C(\NCC(C)N1CCOCC1C)N1CCN(c2cc(F)ccc2F)CC1.I
InChIInChI=1S/C20H31F2N5O.HI/c1-15(27-10-11-28-14-16(27)2)13-24-20(23-3)26-8-6-25(7-9-26)19-12-17(21)4-5-18(19)22;/h4-5,12,15-16H,6-11,13-14H2,1-3H3,(H,23,24);1H
InChIKeyIVARJRAUKXOWBL-UHFFFAOYSA-N
XLogP2.39
TPSA43.34 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500523.41
LogP ≤ 52.39
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide?
The IUPAC name of 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide (CID 109450574) is 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide.
What is the SMILES notation for 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide?
The canonical SMILES for 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide is C/N=C(\NCC(C)N1CCOCC1C)N1CCN(c2cc(F)ccc2F)CC1.I.
What is the InChIKey of 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide?
The InChIKey is IVARJRAUKXOWBL-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H31F2N5O.HI/c1-15(27-10-11-28-14-16(27)2)13-24-20(23-3)26-8-6-25(7-9-26)19-12-17(21)4-5-18(19)22;/h4-5,12,15-16H,6-11,13-14H2,1-3H3,(H,23,24);1H.
What are the key properties of 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide?
4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide has a molecular weight of 523.41 g/mol, XLogP of 2.39, 4 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(2,5-difluorophenyl)-N'-methyl-N-[2-(3-methylmorpholin-4-yl)propyl]piperazine-1-carboximidamide;hydroiodide is sourced from PubChem (CID 109450574), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).